XU SHUICHAN,HEGE KRISTEN MAE,RAYMON HEATHER,NARLA RAMA K.
申请号:
NZ62840713
公开号:
NZ628407A
申请日:
2013.03.14
申请国别(地区):
NZ
年份:
2016
代理人:
摘要:
Provided herein are methods for treating or preventing triple negative breast cancer or hormone receptor positive breast cancer, comprising administering an effective amount of a TOR kinase inhibitor such as 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one to a patient having triple negative breast cancer or hormone receptor positive breast cancer.